reporter.mcgill.ca
Open in
urlscan Pro
208.97.152.239
Public Scan
Submitted URL: http://emclick.imodules.com/ls/click?upn=kvd7qtlpbnPMyMW2BQB7tpbqwwKT37DTNolOBJ-2FDy5icSLV6VRXt9WiAMKBvGwvamZ3i1wJ2JVUvcm23C...
Effective URL: https://reporter.mcgill.ca/165-million-for-mcgill-universitys-world-leading-inclusive-genomics-and-rna-research-program/
Submission: On May 03 via manual from CA — Scanned from CA
Effective URL: https://reporter.mcgill.ca/165-million-for-mcgill-universitys-world-leading-inclusive-genomics-and-rna-research-program/
Submission: On May 03 via manual from CA — Scanned from CA
Form analysis
3 forms found in the DOMGET https://reporter.mcgill.ca/
<form role="search" method="get" class="search-form" action="https://reporter.mcgill.ca/">
<label>
<input type="search" class="search-field form-control" placeholder="Search the McGill Reporter..." value="" name="s" title="Search for:">
</label>
<input type="submit" class="search-submit btn btn-default" aria-label="Search" value="">
</form>
POST
<form method="post" enctype="multipart/form-data" data-uploading="false" class="wpd_comm_form wpd_main_comm_form">
<div class="wpd-field-comment">
<div class="wpdiscuz-item wc-field-textarea">
<div class="wpdiscuz-textarea-wrap ">
<div class="wpd-avatar">
<img src="https://reporter.mcgill.ca/wp-content/uploads/2018/04/anon.png" width="54" height="56" alt="guest" class="avatar avatar-56 wp-user-avatar wp-user-avatar-56 photo avatar-default">
</div>
<div id="wpd-editor-wraper-0_0" style="">
<label style="display: none;" for="wc-textarea-0_0">Label</label>
<div id="wpd-editor-0_0" class="ql-container ql-snow" style="border-bottom: 1px solid rgb(221, 221, 221);">
<div class="ql-editor ql-blank" data-gramm="false" contenteditable="true" data-placeholder="Be part of the conversation—share your voice!">
<p><br></p>
</div>
<div class="ql-clipboard" contenteditable="true" tabindex="-1"></div>
<div class="ql-tooltip ql-hidden"><a class="ql-preview" target="_blank" href="about:blank"></a><input type="text" data-formula="e=mc^2" data-link="https://example.com"
data-video="Embed URL"><a class="ql-action"></a><a class="ql-remove"></a></div>
<div class="ql-texteditor"><textarea id="wc-textarea-0_0" name="wc_comment" class="wc_comment wpd-field" style="display: none;"></textarea></div>
</div>
<div id="wpd-editor-toolbar-0_0" class="wpd-toolbar-hidden ql-toolbar ql-snow">
<div class="wpd-editor-buttons-right">
</div>
</div>
</div>
</div>
</div>
</div>
<div class="wpd-form-foot">
<div class="wpdiscuz-textarea-foot">
<div class="wpdiscuz-button-actions"></div>
</div>
<div class="wpd-form-row">
<div class="wpd-form-col-full">
<p>To encourage thoughtful and respectful conversations, comments appear with first and last names (no pseudonyms) and may be published in whole or in part, at the discretion of the Reporter. Please be constructive and respectful; all
comments are moderated according to the <a href="https://reporter.mcgill.ca/guidelines-for-online-comments/">Reporter’s guidelines</a>. We reserve the right to close comments on individual stories. Please note that the University does not
endorse the opinions expressed in comments.</p>
</div>
<div class="clearfix"></div>
</div>
<div class="wpd-form-row">
<div class="wpd-form-col-left">
<div class="wpdiscuz-item wc_name-wrapper wpd-has-icon">
<div class="wpd-field-icon"><svg class="svg-inline--fa fa-user fa-w-16" aria-hidden="true" data-fa-processed="" data-prefix="fas" data-icon="user" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor"
d="M96 160C96 71.634 167.635 0 256 0s160 71.634 160 160-71.635 160-160 160S96 248.366 96 160zm304 192h-28.556c-71.006 42.713-159.912 42.695-230.888 0H112C50.144 352 0 402.144 0 464v24c0 13.255 10.745 24 24 24h464c13.255 0 24-10.745 24-24v-24c0-61.856-50.144-112-112-112z">
</path>
</svg><!-- <i class="fas fa-user"></i> --></div>
<input id="wc_name-0_0" value="" required="required" aria-required="true" class="wc_name wpd-field" type="text" name="wc_name" placeholder="Name*" maxlength="50" pattern=".{3,50}" title="">
<label for="wc_name-0_0" class="wpdlb">Name*</label>
</div>
<div class="wpdiscuz-item wc_email-wrapper wpd-has-icon">
<div class="wpd-field-icon"><svg class="svg-inline--fa fa-at fa-w-16" aria-hidden="true" data-fa-processed="" data-prefix="fas" data-icon="at" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor"
d="M256 8C118.941 8 8 118.919 8 256c0 137.059 110.919 248 248 248 48.154 0 95.342-14.14 135.408-40.223 12.005-7.815 14.625-24.288 5.552-35.372l-10.177-12.433c-7.671-9.371-21.179-11.667-31.373-5.129C325.92 429.757 291.314 440 256 440c-101.458 0-184-82.542-184-184S154.542 72 256 72c100.139 0 184 57.619 184 160 0 38.786-21.093 79.742-58.17 83.693-17.349-.454-16.91-12.857-13.476-30.024l23.433-121.11C394.653 149.75 383.308 136 368.225 136h-44.981a13.518 13.518 0 0 0-13.432 11.993l-.01.092c-14.697-17.901-40.448-21.775-59.971-21.775-74.58 0-137.831 62.234-137.831 151.46 0 65.303 36.785 105.87 96 105.87 26.984 0 57.369-15.637 74.991-38.333 9.522 34.104 40.613 34.103 70.71 34.103C462.609 379.41 504 307.798 504 232 504 95.653 394.023 8 256 8zm-21.68 304.43c-22.249 0-36.07-15.623-36.07-40.771 0-44.993 30.779-72.729 58.63-72.729 22.292 0 35.601 15.241 35.601 40.77 0 45.061-33.875 72.73-58.161 72.73z">
</path>
</svg><!-- <i class="fas fa-at"></i> --></div>
<input id="wc_email-0_0" value="" required="required" aria-required="true" class="wc_email wpd-field" type="email" name="wc_email" placeholder="Email*">
<label for="wc_email-0_0" class="wpdlb">Email*</label>
</div>
</div>
<div class="wpd-form-col-right">
<div class="wc-field-submit">
<input id="wpd-field-submit-0_0" class="wc_comm_submit wpd_not_clicked wpd-prim-button" type="submit" name="submit" value="Post Comment">
</div>
</div>
<div class="clearfix"></div>
</div>
</div>
<input type="hidden" class="wpdiscuz_unique_id" value="0_0" name="wpdiscuz_unique_id">
<input type="hidden" name="JBwdEnjhtxo" value="h60nL*ZIdCNTAUMy"><input type="hidden" name="IhAZSeiavEjPnNO" value="jNA0Wt4drL.">
</form>
POST
<form method="post" enctype="multipart/form-data" data-uploading="false" class="wpd_comm_form wpd-secondary-form-wrapper">
<div class="wpd-field-comment">
<div class="wpdiscuz-item wc-field-textarea">
<div class="wpdiscuz-textarea-wrap ">
<div class="wpd-avatar">
<img src="https://reporter.mcgill.ca/wp-content/uploads/2018/04/anon.png" width="54" height="56" alt="guest" class="avatar avatar-56 wp-user-avatar wp-user-avatar-56 photo avatar-default">
</div>
<div id="wpd-editor-wraper-wpdiscuzuniqueid" style="display: none;">
<div id="wpd-editor-char-counter-wpdiscuzuniqueid" class="wpd-editor-char-counter"></div>
<label style="display: none;" for="wc-textarea-wpdiscuzuniqueid">Label</label>
<textarea id="wc-textarea-wpdiscuzuniqueid" name="wc_comment" class="wc_comment wpd-field"></textarea>
<div id="wpd-editor-wpdiscuzuniqueid" style="border-bottom: 1px solid rgb(221, 221, 221);"></div>
<div id="wpd-editor-toolbar-wpdiscuzuniqueid" class="wpd-toolbar-hidden">
<div class="wpd-editor-buttons-right">
</div>
</div>
</div>
</div>
</div>
</div>
<div class="wpd-form-foot">
<div class="wpdiscuz-textarea-foot">
<div class="wpdiscuz-button-actions"></div>
</div>
<div class="wpd-form-row">
<div class="wpd-form-col-full">
<p>To encourage thoughtful and respectful conversations, comments appear with first and last names (no pseudonyms) and may be published in whole or in part, at the discretion of the Reporter. Please be constructive and respectful; all
comments are moderated according to the <a href="https://reporter.mcgill.ca/guidelines-for-online-comments/">Reporter’s guidelines</a>. We reserve the right to close comments on individual stories. Please note that the University does not
endorse the opinions expressed in comments.</p>
</div>
<div class="clearfix"></div>
</div>
<div class="wpd-form-row">
<div class="wpd-form-col-left">
<div class="wpdiscuz-item wc_name-wrapper wpd-has-icon">
<div class="wpd-field-icon"><svg class="svg-inline--fa fa-user fa-w-16" aria-hidden="true" data-fa-processed="" data-prefix="fas" data-icon="user" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor"
d="M96 160C96 71.634 167.635 0 256 0s160 71.634 160 160-71.635 160-160 160S96 248.366 96 160zm304 192h-28.556c-71.006 42.713-159.912 42.695-230.888 0H112C50.144 352 0 402.144 0 464v24c0 13.255 10.745 24 24 24h464c13.255 0 24-10.745 24-24v-24c0-61.856-50.144-112-112-112z">
</path>
</svg><!-- <i class="fas fa-user"></i> --></div>
<input id="wc_name-wpdiscuzuniqueid" value="" required="required" aria-required="true" class="wc_name wpd-field" type="text" name="wc_name" placeholder="Name*" maxlength="50" pattern=".{3,50}" title="">
<label for="wc_name-wpdiscuzuniqueid" class="wpdlb">Name*</label>
</div>
<div class="wpdiscuz-item wc_email-wrapper wpd-has-icon">
<div class="wpd-field-icon"><svg class="svg-inline--fa fa-at fa-w-16" aria-hidden="true" data-fa-processed="" data-prefix="fas" data-icon="at" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor"
d="M256 8C118.941 8 8 118.919 8 256c0 137.059 110.919 248 248 248 48.154 0 95.342-14.14 135.408-40.223 12.005-7.815 14.625-24.288 5.552-35.372l-10.177-12.433c-7.671-9.371-21.179-11.667-31.373-5.129C325.92 429.757 291.314 440 256 440c-101.458 0-184-82.542-184-184S154.542 72 256 72c100.139 0 184 57.619 184 160 0 38.786-21.093 79.742-58.17 83.693-17.349-.454-16.91-12.857-13.476-30.024l23.433-121.11C394.653 149.75 383.308 136 368.225 136h-44.981a13.518 13.518 0 0 0-13.432 11.993l-.01.092c-14.697-17.901-40.448-21.775-59.971-21.775-74.58 0-137.831 62.234-137.831 151.46 0 65.303 36.785 105.87 96 105.87 26.984 0 57.369-15.637 74.991-38.333 9.522 34.104 40.613 34.103 70.71 34.103C462.609 379.41 504 307.798 504 232 504 95.653 394.023 8 256 8zm-21.68 304.43c-22.249 0-36.07-15.623-36.07-40.771 0-44.993 30.779-72.729 58.63-72.729 22.292 0 35.601 15.241 35.601 40.77 0 45.061-33.875 72.73-58.161 72.73z">
</path>
</svg><!-- <i class="fas fa-at"></i> --></div>
<input id="wc_email-wpdiscuzuniqueid" value="" required="required" aria-required="true" class="wc_email wpd-field" type="email" name="wc_email" placeholder="Email*">
<label for="wc_email-wpdiscuzuniqueid" class="wpdlb">Email*</label>
</div>
</div>
<div class="wpd-form-col-right">
<div class="wc-field-submit">
<input id="wpd-field-submit-wpdiscuzuniqueid" class="wc_comm_submit wpd_not_clicked wpd-prim-button" type="submit" name="submit" value="Post Comment">
</div>
</div>
<div class="clearfix"></div>
</div>
</div>
<input type="hidden" class="wpdiscuz_unique_id" value="wpdiscuzuniqueid" name="wpdiscuz_unique_id">
<input type="hidden" name="JBwdEnjhtxo" value="h60nL*ZIdCNTAUMy"><input type="hidden" name="IhAZSeiavEjPnNO" value="jNA0Wt4drL.">
</form>
Text Content
Skip to content mcgill.ca * Headline News * General News * Urgent communication * In Focus * Editorial * Obituaries * McGill dans la ville * Research * Research News * Notes from the field * Events * Arts & Culture * Music and Theatre * Visual Arts * Literature * Kudos * Prizes * Appointments * Rankings * Sustainability * Sustainability News * Equity, Diversity, and Inclusion mcgill.ca $165-MILLION FOR MCGILL UNIVERSITY’S WORLD-LEADING INCLUSIVE GENOMICS AND RNA RESEARCH PROGRAM The Government of Canada awards McGill the largest research grant in the University’s history to create an international hub for “next generation” medicines By Meaghan Thurston, Associate Director, Research Communications April 28, 2023 1 Comment La version française suit le texte anglais The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced $1.4 billion in support of 11 large-scale research initiatives through the Canada First Research Excellence Fund (CFREF) today at Concordia University in Montreal. The CFREF grants are awarded through a highly competitive process to the top programs in their fields. McGill is the recipient of a landmark $165 million CFREF grant to launch DNA to RNA: An Inclusive Canadian Approach to Genomic-based RNA Therapeutics (D2R), a first-of-its-kind global research effort specializing in the development and delivery of more inclusive genomic-based RNA therapeutics. D2R will receive significant support from more than 50 partners, including many from academia and industry, who have all pledged to invest in the research, which brings the total amount invested in D2R to $353 million. Canadian academic partnering institutions include the University of Ottawa, the University of British Columbia (UBC), McMaster University and l’Université de Sherbrooke. “McGill’s commitments to RNA and genomics sciences over several decades have built a critical mass of researchers and exceptional facilities to lead the RNA therapeutics revolution,” says Martha Crago, Vice-Principal, Research and Innovation. “This significant research investment will open a new frontier in the treatment of diseases and disorders.” “McGill is grateful to the Government of Canada and an impressive group of global partners for their support of this world-leading, inclusive program of research excellence and innovation,” says Deep Saini, Principal and Vice-Chancellor of McGill. THE RNA REVOLUTION The remarkable and rapid success of mRNA vaccines against SARS-CoV-2 demonstrated the power of combining genomics with RNA technology. RNA therapeutics can be developed and produced much more quickly than traditional small molecule drugs, which can take years to discover and cost billions to produce. D2R-led research has the potential to provide breakthrough treatments for a wide spectrum of diseases, such as those caused by emerging viruses that threaten our society with pandemics, rare genetic disorders that are incurable or prohibitively expensive to treat, and cancer, which is the number one cause of death in Canada. “To treat complex conditions and their associated catastrophic health and economic consequences more effectively, we need to work across sectors and with an engaged group of partners,” says Mark Lathrop, Scientific Director of the McGill Genome Centre, and the Scientific Director of D2R. “D2R is creating a nexus for genomics and RNA research and demonstrating leadership in the implementation of inclusive social and regulatory policies to address global health needs.” AN INCLUSIVE APPROACH The team of seventy researchers from five academic institutions, will work collaboratively with Canada’s Indigenous and immigrant populations, including with the partnering Network Environments for Indigenous Health Research (NEIHR), to ensure the promise of RNA therapeutics is made widely available in a manner that is inclusive and beneficial to all Canadians. Training of students and postdocs and support for early career researchers are core priorities of D2R, as is interdisciplinary work among researchers in AI, data science and RNA therapeutics, RNA biology, social sciences, law, ethics, and Indigenous heath. “The D2R Initiative will develop safe and effective therapies, focus on creating more inclusive genomic datasets, and work to break down historical barriers to medicines and care through close partnership with equity-deserving communities,” says Amélie Quesnel-Vallée, Canada Research Chair in Policies and Health Inequalities, Inaugural Chair of the Department of Equity, Ethics and Policy at McGill, and D2R’s Co-Scientific Director. EXCELLENCE SPANNING DECADES AND INSTITUTIONS The D2R Initiative builds on McGill’s 50-year history in RNA discovery and innovation. This includes researchers such as Prof. Nahum Sonenberg who in 1976 first identified the cap-binding protein eIF4E, a key component in RNA’s ability to regulate the replication of cells. Also, a member of the D2R team is University of British Columbia’s Dr. Pieter Cullis, whose work in lipid nanoparticles was an essential precursor to the later development of mRNA vaccines. Several Fortune 500 pharmaceutical companies are engaged with D2R. Eight additional academic partners, including five international partners, have also joined forces on this initiative. RELATED LINKS: The RNA Revolution Government of Canada press release Watch the video below ____________________ 165 MILLIONS POUR UN PROGRAMME DE RECHERCHE INCLUSIF DE CLASSE MONDIALE SUR LA GÉNOMIQUE ET L’ARN Le gouvernement du Canada accorde à l’Université McGill une subvention d’une ampleur inédite pour la création d’une plateforme internationale de traitements novateurs. L’Honourable François-Philippe Champagne, Ministre de l’Innovation, des Sciences et de l’Industrie, a annoncé aujourd’hui à l’Université Concordia (Montréal) un investissement de 1,4 milliard de dollars pour soutenir 11 initiatives de recherche à grande échelle dans le cadre du Fonds d’excellence en recherche Apogée Canada (fonds Apogée). Les subventions du fonds Apogée sont attribuées aux meilleurs programmes d’un domaine à la suite d’un processus hautement concurrentiel. McGill recevra un financement majeur de 165 millions de dollars du fonds Apogée pour lancer le projet De l’ADN à l’ARN : une approche canadienne inclusive des traitements génomiques à base d’ARN (D2R), une initiative de recherche unique en son genre qui vise au développement de nouveaux traitements à base d’ARN plus inclusifs. Le programme recevra un soutien important de plus de 50 partenaires, dont bon nombre proviennent du milieu universitaire et du secteur privé et dont la contribution promise amènera l’investissement total à 353 millions de dollars. Parmi les établissements partenaires canadiens, on peut compter l’Université d’Ottawa, l’Université de la Colombie-Britannique, l’Université McMaster et l’Université de Sherbrooke. « McGill œuvre en génomique et en ARN depuis plusieurs décennies; cela lui a permis de se donner une masse critique de scientifiques et des installations exceptionnelles pour révolutionner les thérapies à ARN, affirme Martha Crago, vice-principale à la recherche et à l’innovation. « Cet important investissement dans la recherche ouvrira une nouvelle frontière dans le traitement des maladies humaines. » « L’Université remercie le gouvernement du Canada et ses partenaires mondiaux exceptionnels pour le soutien apporté à ce programme inclusif d’excellence et d’innovation en recherche de calibre international, » affirme Deep Saini, principal et vice-chancelier. LA RÉVOLUTION DE L’ARN L’efficacité remarquable et rapide des vaccins à ARNm contre le SRAS-CoV-2 a démontré le potentiel de la génomique combinée à la technologie à ARN. Les traitements à ARN peuvent être mis au point et produits beaucoup plus vite que les classiques médicaments à petites molécules, dont la découverte demande des années de travail et les coûts de production se chiffrent en milliards de dollars. La recherche en D2R pourrait donner lieu à des traitements révolutionnaires pour tout un éventail de maladies, dont celles causées par des virus émergents qui menacent de causer des pandémies, des troubles génétiques rares et incurables ou au traitement ruineux, ou des cancers – la première cause de décès au pays. « Pour traiter plus efficacement des problèmes de santé complexes et leurs conséquences sanitaires et économiques, nous devons décompartimenter la recherche et travailler avec un groupe de partenaires engagés », explique Mark Lathrop, directeur scientifique du Centre d’innovation Génome Québec et Université McGill et directeur scientifique de D2R. « En plus de créer un pôle de recherche sur la génomique et l’ARN, le programme D2R donne l’exemple en matière d’application de politiques sociales et réglementaires inclusives pour répondre aux besoins en santé dans le monde. » UNE APPROCHE INCLUSIVE L’équipe de 70 chercheuses et chercheurs de cinq établissements travaillera en collaboration avec les populations autochtones et immigrantes du pays, dont son partenaire Environnement réseau pour la recherche sur la santé des Autochtones (ERRSA), pour offrir les prometteurs traitements à ARN de manière inclusive et avantageuse à tout le Canada. Parmi ses grandes priorités, le projet D2R compte la formation des étudiantes, étudiants et stagiaires postdoctoraux et le soutien aux chercheuses et chercheurs en début de carrière; il mise aussi sur l’interdisciplinarité en réunissant des scientifiques de l’IA, de la science des données, des traitements à ARN, de la biologie de l’ARN, des sciences sociales, du droit, de l’éthique et de la santé autochtone. « L’initiative D2R mettra au point des traitements sûrs et efficaces, visera la création d’ensembles de données génomiques plus inclusifs, et cherchera à aplanir les obstacles historiques à l’administration de soins et de traitements grâce à un partenariat étroit avec les communautés en quête d’équité, explique Amélie Quesnel-Vallée, titulaire de la Chaire de recherche du Canada en politiques et inégalités sociales de santé, première directrice du Département d’équité, d’éthique et de politiques de McGill et codirectrice scientifique de D2R. L’EXCELLENCE À TRAVERS LES ÂGES ET LES ÉTABLISSEMENTS L’initiative D2R table sur cinquante années de découvertes et d’innovation sur l’ARN à l’Université McGill. C’est notamment le fait de scientifiques comme Prof. Nahum Sonenberg, qui a découvert en 1976 la protéine eIF4E, qui se lie à la coiffe de l’ARNm et constitue l’une des clés de la capacité de l’ARN à réguler la réplication des cellules. Pensons également à l’un des membres de l’équipe D2R, Pieter Cullis (Université de la Colombie-Britannique), dont les travaux sur les nanoparticules lipidiques ont joué un rôle essentiel dans l’avènement des vaccins à ARNm. Plusieurs pharmaceutiques du classement Fortune 500 se sont aussi engagées à soutenir D2R. Huit autres partenaires universitaires, donc cinq à l’étranger, se sont aussi joints à l’initiative. LIENS ASSOCIÉS : La révolution de l’ARN Communiqué de presse Login with Label To encourage thoughtful and respectful conversations, comments appear with first and last names (no pseudonyms) and may be published in whole or in part, at the discretion of the Reporter. Please be constructive and respectful; all comments are moderated according to the Reporter’s guidelines. We reserve the right to close comments on individual stories. Please note that the University does not endorse the opinions expressed in comments. Name* Email* Login with Label To encourage thoughtful and respectful conversations, comments appear with first and last names (no pseudonyms) and may be published in whole or in part, at the discretion of the Reporter. Please be constructive and respectful; all comments are moderated according to the Reporter’s guidelines. We reserve the right to close comments on individual stories. Please note that the University does not endorse the opinions expressed in comments. Name* Email* 1 Comment Oldest Newest Most Voted Inline Feedbacks View all comments Jocelyn Simon Daigle 1 day ago Share On Facebook Awesome ! This was much needed Jocelyn Simon Daigle, M.Sc(A) McGill 96′ 0 Reply YOU MIGHT ALSO ENJOY... Headline News WE SEE YOU January 11, 2023 Kudos MCGILL CELEBRATES ITS HIGHLY CITED RESEARCHERS November 22, 2022 Kudos ELENA BENNETT ELECTED TO THE NATIONAL ACADEMY OF SCIENCES May 5, 2022 Headline News | PRIME MINISTER TRUDEAU, PREMIER LEGAULT VISIT CAMPUS TO WELCOME... April 29, 2022 Load more The McGill Reporter is McGill University‘s journal of record. -------------------------------------------------------------------------------- Looking for more news, videos and expert opinions? Try the McGill Newsroom. Looking for our archives? Visit the McGill Reporter archives. MCGILL BICENTENNIAL EQUITY, DIVERSITY, AND INCLUSION HEADLINE NEWS * Culture and Arts * General News * Urgent communication * In Focus * Arts & Culture * Editorial * Obituaries RESEARCH * WEF * Research News * Notes from the field * Events ATHLETICS * Varsity Athletics * Club Sports * Recreation * Health * Awards and Accolades * Game Changers KUDOS * Honours * Scholarships * Fellowships * Prizes * Appointments * Rankings SUSTAINABILITY * Sustainability News * Vision 2020 LE FRENCH SIDE DE MCGILL * Portraits * McGill dans la ville * McGill en français ABOUT THE REPORTER The McGill Reporter is McGill University‘s journal of record. -------------------------------------------------------------------------------- Looking for more news, videos and expert opinions? Try the McGill Newsroom. Looking for our archives? Visit the McGill Reporter archives. Insert